Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
In particular, thrombocytopenia, a condition characterized by low circulating platelet count, has been observed with Navitoclax administration [205] and D + Q administration has been reported to have several side effects including hematologic dysfunction, fluid retention and QT prolongation, and state of the extended electrical interval between the heart's contraction and relaxation [206]
2016 Aug 22;11(8):e0160755
:max_bytes(150000):strip_icc()/taking-supplements-GettyImages-1481097930-2055b107e5ab450aaa762e4b070da9a1.jpg)
Rengby O, Johansson L, Carlson LA, Serini E, Vlamis-Gardikas A, et al
PubMed 8
US$ 20.33
US$ 22.07
US$ 26.79
/assets/production/practices/983d8d073a64c8b3033f42879fbf39645b7f7127/images/2838887.png)
US$ 29.47
US$ 26.35
US$ 25.86
